Search results
Results from the WOW.Com Content Network
The Family Smoking Prevention and Tobacco Control Act (also known as the FSPTC Act) was signed into law by President Barack Obama on June 22, 2009. This bill changed the scope of tobacco policy in the United States by giving the FDA the ability to regulate tobacco products, similar to how it has regulated food and pharmaceuticals since the passing of the Pure Food and Drug Act in 1906.
The Food and Drug Administration's new guidance could ban retailers that do not have age-restricted areas of the store from selling flavored tobacco products for e-cigarettes and pushes up the ...
As part of a rule finalized by the agency on Thursday, the FDA now requires retailers to verify the age of anyone under 30 when they buy tobacco products, from under 27 previously. The FDA also ...
(Reuters) - The U.S. Food and Drug Administration on Tuesday said it would allow Philip Morris to sell a heated tobacco product called IQOS in the United States, a major victory for the ...
Family Smoking Prevention and Tobacco Control Act; Long title: To protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products, to amend title 5, United States Code, to make certain modifications in the Thrift Savings Plan, the Civil Service Retirement System, and the Federal Employees’ Retirement System, and for other purposes.
Anti-smoking campaigners may regard this as a contradiction, while pharmacies state that, by selling tobacco, they are able to offer stop-smoking products directly to smokers at the point of sale. [1] A tobacco-free pharmacy is a retail pharmacy where the sale of tobacco products is not available. Outside the United States, it is illegal in ...
Vuse is the top-selling e-cigarette brand in the country, according to Nielsen data, comprising more than 40 percent of the market. ... FDA allows sale of best-selling tobacco e-cigarette Vuse ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...